CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease
Neurology News Network for the week ending April 4, 2020.
NeurologyLive Friday 5 — April 3, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 3, 2020.
Mayo Clinic Neurology Taps Video Technology to Maintain Care During COVID-19
Mayo Clinic is in the forefront of changing practice techniques during the COVID-19 pandemic by using video appointments to reach patients.
Please Donate Blood!
NeurologyLive’s parent company, MJH Life Sciences, will be hosting the virtual MJH Life Sciences Sleeves Up Blood Drive from March 31 through April 30.
Webinar: Multiple Sclerosis Management During COVID-19
Watch Mitzi J. Williams, MD, lead a discussion of the latest best practice guidance and real-world cases of COVID-19 in patients with multiple sclerosis.
FDA Approves Ozanimod, Intrathecal Zolgensma Results Released, NDA Accepted for JZP-258
Neurology News Network for the week ending March 28.
NeurologyLive Friday 5 — March 27, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 27, 2020.
Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast
Neurology News Network for the week ending March 21, 2020.
NeurologyLive Friday 5 — March 20, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 20, 2020.
Webinar: Outpatient Telemedicine Billing and Coding in the Age of COVID-19
The webinar, a partnership between Women Neurologist's Group (WNG) and NeurologyLive, features the latest updates from CMS on billing and coding for telemedicine visits.
Coronavirus and Tuberous Sclerosis Complex: What You Need to Know
The Tuberous Sclerosis Alliance (TS Alliance) have prepared an FAQ to address concerns from the tuberous sclerosis complex (TSC) community regarding the COVID-19 outbreak.
Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update
Neurology News Network for the week ending March 14, 2020.
NeurologyLive Friday 5 — March 13, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 13, 2020.
FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available
Neurology News Network for the week ending March 7, 2020.
NeurologyLive Friday 5 — March 6, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 6, 2020.
New Study Shows Vision Rehab Treatment Effective For Stroke and Injury Related Blindness
The NeuroEyeCoach visual rehabilitation therapy applied after stroke or other traumatic brain injury (TBI) improved vision in over 80 percent of patients
NeurologyLive Friday 5 — February 28, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 28, 2020.
NeurologyLive Launches "Updates to the MRI Protocol and Clinical Guidelines for MS" Video Series Along With the Consortium of Multiple Sclerosis Centers
The multi-part series features a panel of 5 distiguished experts, discussing topics related to the updates to MRI and guidelines for multiple sclerosis treatment.
FDA Approves Programmable Pump System for Spasticity, Revised Treatment Recommendations for Spinal Muscular Atrophy, OnabotulinumtoxinA Trial Results
Neurology News Network for the week ending February 22, 2020.
NeurologyLive Friday 5 — February 21, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 21, 2020.
Sabril Label Expanded for Patients 2 to 10 Years Old
The previously approved therapy is now indicated for treatment in pediatric patients age 2 to 10.
Bcureful and Tuberous Sclerosis Alliance Announce Plans to Combine Efforts
The announcement formally connects Bcureful and the Tuberous Sclerosis Alliance together after working closely together for over the past 8 years.
Important Information About Changes to Access and Availability of Generic Everolimus and Afinitor
The Tuberous Sclerosis Alliance has announced updates to access of everolimus, a drug used to treat several conditions associated with tuberous sclerosis complex.
NDA Green Lighted For Diazepam Buccal Film, Solanezumab and Gantenerumab Fail in Alzheimer Trial, Mind Moments Episode 7 Live
Neurology News Network for the week ending February 15, 2020.
NeurologyLive Friday 5 — February 14, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 14, 2020.
NDA Submitted For CBD in Tuberous Sclerosis Complex, Ataluren Improves Walking Ability in DMD, Lasmiditan Available in Pharmacies
Neurology News Network for the week ending February 8, 2020.
NeurologyLive Friday 5 — February 7, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 7, 2020.
New ICD-10 Codes Added for Dravet Syndrome
The new codes listed by the World Health Organization include changes to Dravet syndrome, status epilepticus, and epilepsy in infants.
Dravet Syndrome Foundation Live Video Education Session
Dravet Syndrome Foundation is pleased to announce a new, live video education session on Thursday, February 13, 2020 at 2pm ET.
Investigational Dyskinesia Treatment Gets FDA Green Light
The FDA has approved the investigational new drug application for AV-101 for the treatment of dyskinesia in patients with Parkinson disease who are treated with levodopa.